These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1164476)

  • 1. Proceedings: Cell mediated immunoreactivity in human lung neoplasia.
    Vose BM; Moore M
    Br J Cancer; 1975 Feb; 31(2):261. PubMed ID: 1164476
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte migration inhibition in human pulmonary neoplasia.
    Vose BM; Kimber I; Moore M
    J Natl Cancer Inst; 1977 Mar; 58(3):483-8. PubMed ID: 839553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of specific anti-tumour immunity in lung cancer patients by means of leukocyte migration inhibition test. The role of antigenic preparations.
    Zeromski J; Jezewska E; Lawniczak M; Górny MK
    Mater Med Pol; 1982; 14(1-2):68-73. PubMed ID: 7186996
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
    Urist MM; Boddie AW; Townsend CM; Holmes EC
    J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Humoral immunity in human lung neoplasms.
    Dawson M; Moore M
    Br J Cancer; 1975 Aug; 32(2):243. PubMed ID: 1212359
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of cellular immunity against urethan-induced lung adenomas of mice.
    Colnaghi MI; Ménard S; Porta GD
    J Natl Cancer Inst; 1971 Dec; 47(6):1325-31. PubMed ID: 5120411
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic aspects of lung cancer.
    Morton DL; Holmes EC; Golub SH
    Chest; 1977 May; 71(5):640-3. PubMed ID: 852344
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 9. Time lapse cinematographic demonstration of humoral and cell mediated immunity in squamous cell carcinoma of the lung.
    Vetterlein M; Auchmann M; Breit P; Cerni C; Micksche M; Wrba H
    Osterr Z Onkol; 1976; 3(4):99-102. PubMed ID: 1037019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: use of the leucocyte-migration test to demonstrate specific cellular immunity in lymph-nodes draining colorectal cancer.
    Guillou PJ; Giles GR
    Br J Surg; 1973 Nov; 60(11):904-5. PubMed ID: 4752759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative characteristics of the cellular link of immunity and a lymphocytic response to tumor-associated antigens in patients with tuberculosis and malignant neoplasms of the lung].
    Autenshlius AI; Ivanova GG; Ogirenko AP; Ageeva TA; Vasil'ev NE
    Probl Tuberk; 2002; (4):48-50. PubMed ID: 12125255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cellular immunity in neoplasia.
    Glade PR; Zaldivar NM; Mayer L; Cahill LT
    Pediatr Res; 1976 May; 10(5):517-22. PubMed ID: 778771
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer.
    McCoy JL; Jerome LF; Cannon GB; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Nov; 59(5):1413-8. PubMed ID: 909101
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
    McCoy JL; Jerome LJ; Cannon GB; Pomeroy TC; Connor RJ; Oldham RK; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Oct; 59(4):1119-25. PubMed ID: 903991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of tumor-specific antigen in squamous cell carcinomas of the lung, using an established bronchial carcinoma line E 14. Short communication.
    Auchmann M; Breit P; Cerni C; Micksche M; Vetterlein M; Wrba H
    Osterr Z Onkol; 1974; (1):26-8. PubMed ID: 4480616
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 17. Some aspects of the cellular and humoral immune response to tumour antigens.
    Hellström KE; Hellström I
    Triangle; 1972; 11(1):23-8. PubMed ID: 4624858
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
    Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
    Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
    [No Abstract]   [Full Text] [Related]  

  • 19. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
    Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
    Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.